STAT3 and non-small cell lung carcinoma: Meanwhile, inhibition of STAT3 with a selective inhibitor S3I-201 sensitizes refractory NSCLC cells to BEZ235 (a dual inhibitor of PI3K and mTOR) and enhances cell death [268].